2023 Agenda

The agenda for the 2023 Psychiatric Pharmacotherapy Update is being finalized.

Sessions listed below are confirmed.

Day I • October 26, 2023


8:30 a.m.	Psychopharmacology Myth-Busting Tawny Smith, Pharm.D., BCPP Associate Professor of Psychiatry The University of Texas at Austin Dell Medical School Marisa S. P. Toups, M.D. Physiatrist / Owner, Singularity Psychiatry and Mental Health Affiliate Assistant Professor UT Southwestern Medical School Department of Psychiatry

9:30 a.m.	*Orexins and Emerging Indications for Use in Psychiatry Beyond Insomnia* Roger W. Sommi, Pharm.D., BCPP, FCCP Professor Emeritus of Pharmacy Practice and Psychiatry Division of Pharmacy Practice and Administration UMKC School of Pharmacy
10:30 a.m.	BREAK
10:45 a.m.	*Update on Substance Use* Lindsey J. Loera, Pharm.D., RPh Assistant Professor of Practice The University of Texas at Austin College of Pharmacy Pharmacy Addictions Research & Medicine (PhARM) Program

11:45 a.m.	Novel Approaches to Metabolic Complications of Antipsychotic Treatment Troy A. Moore, Pharm.D., M.S. Pharm., BCPP Director, ASHP Accredited PGY-1 Pharmacy Residency Program Clinical Pharmacy Specialist, Mental Health Rocky Mountain Regional VA Medical Center
12:45 p.m.	LUNCH and REFLECTION
1:45 p.m.	Psychotropic New Drug Update Stephen R. Saklad, Pharm.D., BCPP Director, Psychiatric Pharmacy Clinical Professor The University of Texas at Austin College of Pharmacy
2:45 p.m.	BREAK
3:00 p.m.	*Pharmacogenomics and Psychiatric Medications* Vicki Ellingrod, Pharm.D., FCCP, FACNP Dean and J. G. Searle Professor of Pharmacy, College of Pharmacy Professor of Psychiatry, Medical School; Adjunct Professor of Psychology, College of Literature, Science, and Arts The University of Michigan

4:00 p.m.	*Cannabis and Mental Health* *Thida Thant, M.D.* Assistant Professor of Psychiatry University of Colorado Medicine

	RECEPTION

Day II • October 27, 2023


8:30 a.m.	Novel Mechanism of Actions for Treatment of Neuropsychiatric Disorders Brett A. English, Pharm.D., Ph.D. Vice President CenExel

9:30 a.m.	Benzodiazepine Deprescribing & Workplace Initiative Lisa M. Mican, Pharm.D., BCPP Director of Pharmacy Clinical Coordinator Austin State Hospital M. Elizabeth Deel Flores, MSN, MS, RN, APRN, PMHNP-BC Assistant Clinical Director Austin State Hospital
10:30 a.m.	BREAK
10:45 a.m.	A Clinician’s Guide to the Management of Behavioral and Psychological Symptoms of Dementia Rajesh R. Tampi, M.D., M.S., DFAPA, DFAAGP Chairman, Department of Psychiatry & Behavioral Sciences Cleveland Clinic Akron General Chief, Section for Geriatric Psychiatry, Cleveland Clinic Professor of Medicine, Cleveland Clinic Lerner College of Medicine of Case Western Reserve University (CCLCM)
11:45 a.m.	LUNCH and REFLECTION
12:45 p.m.	Pharmacology in Gender-Affirming Care Carol A. Ott, Pharm.D., MPH, BCPP (pronouns: she/her) Clinical Professor of Pharmacy Practice Clinical Pharmacy Specialist Psychiatry and Gender Health, Eskenazi Health Purdue University College of Pharmacy
1:45 p.m.	BREAK
2:00 p.m.	Antipsychotics in Pregnancy and Lactation Jeffrey Newport, M.D. Director of Women’s Reproductive Mental Health UT Health Austin

3:00 p.m.	Pediatric Depression Update Lynn Crismon, Pharm.D., FCCP, DABCP, BCPP Professor of Pharmacy & Psychiatry The University of Texas at Austin College of Pharmacy

4:00 p.m.	ADJOURN

On-Demand Content


	Gabapentinoid Misuse: An Unnerving New Trend Kirk Evoy, Pharm.D., BCACP, BC-ADM, CTTS Clinical Assistant Professor The University of Texas at Austin College of Pharmacy

	Breaking Issues in Opioid Use Disorder Treatment and Harm Reduction Lucas Hill, Pharm.D., BACACP Clinical Associate Professor The University of Texas at Austin College of Pharmacy Director, Pharmacy Addictions Research & Medicine Program

	Using the PMP and Communicating with Patients Concerning Controlled Substance Prescriptions Dr. K. Ashley Garling-Nañez, Pharm.D. Clinical Assistant Professor The University of Texas at Austin College of Pharmacy

	Pain Management: Pain Management in the Hospital Lyndsi Meyenburg, Pharm.D., BCPS Clinical Pharmacy Specialist, Internal Medicine Residency Program Director, PGY2 Internal Medicine Pharmacy Residency, Pharmacy Department, Ascension Seton

	Managing Buprenorphine in Hospitalized Patients with Opioid Use Disorder Kristin Janzen, Pharm.D., BCPS Clinical Assistant Professor, Pharmacy Practice The University of Texas at Austin College of Pharmacy Internal Medicine Clinical Specialist, Dell Seton Medical Center

	Prescribing and Monitoring Controlled Substances: 2022 CDC Guideline for Prescribing Opioids for Pain Stefan Kertesz, M.D., MsC Professor Heerslink School of Medicine, University of Alabama Birmingham

	Tools and Perspectives for Responding to the Drug Shortages Panel TBA Moderator: Charles Maina, Pharm.D. UT Hospital San Antonio

	Stigma Kills – Addressing Opioid and Substance Use Disorder by Changing Health System Culture Richard Bottner, DHA, PA-C, CPHQ, FACHE Vice President, Clinical Excellence Colorado Hospital Association

Agenda is subject to change.

System Requirements

Please ensure the computer system you plan to use meets the following minimum requirements:

Operating System: Windows 7 or higher, macOS Sierra (10.12) or higher
Internet Browser: Chrome 30 or higher, Firefox 27 or higher, Internet Explorer 11, Microsoft Edge, Safari 9 or higher
Internet connection: Cable, High-speed DSL, and any other medium that is internet accessible
Peripherals: Computer speakers or headphones
Media Viewing Requirements: Adobe Reader, HTML5

Educational Disclaimer

The authors of this continuing education activity have made reasonable efforts to ensure that all information contained herein is accurate in accordance with the latest available scientific evidence at the time of publication. However, because information regarding medications, treatment guidelines, and other healthcare information is subject to constant change, the participant is advised to always confirm practice resources before applying any learned information in practice. Activities produced by Texas Pharmacy’s Center for Continuing Professional Development are intended solely for purposes of supplementing preceptor professionals’ knowledge. The opinions expressed in this educational activity are those of the faculty and do not necessarily represent the views of The University of Texas at Austin College of Pharmacy.